ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
CEBINA Reports Positive Findings on Azelastine Potency for COVID-19 americanpharmaceuticalreview
September 27, 2020CEBINA GmbH has announced further positive results in its collaborative COVID-19 drug repurposing project, demonstrating allergy nasal spray medication containing azelastine has potent efficacy against SARS-CoV-2 in a human 3D nasal tissue model.
Pharma Sources Insight January 2025
